Central Nervous System Protozoal Infections: Clinical Trials

7 trials for Central Nervous System Protozoal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 unknown, 1 terminated. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Unknown 3, Terminated 1
Phase 21Unknown 1

Follow Central Nervous System Protozoal Infections: new trials by email Literature Review of Central Nervous System Protozoal Infections trials Research Report on Central Nervous System Protozoal Infections

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treating Brain Swelling in Pediatric Cerebral Malaria
Mechanical ventilation, Hypertonic saline - Malaria, Cerebral
Phase 3CompletedMichigan State University572018-01-082025-03-17
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Immunochromatographic HAT tests (DSD), Card Agglutination Trypanosoma Test, TB POC Nucleic Acid Amplification Test (Molbio Diagnostics) - Neurological Disorders, Cerebral Malaria
Phase 3CompletedInstitute of Tropical Medicine, Belgium3522012-09-012016-01-18
Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Pyrimethamine/Sulfadiazine, Spiramycine - Congenital Toxoplasmosis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1492010-11-012016-09-29
Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
reducing treatment to 3 months, registered length of treatment - Congenital Toxoplasmosis
Phase 3TerminatedCentre Hospitalier Universitaire Dijon3022010-07-282024-02-22
Randomized Trial of Erythropoietin During Cerebral Malaria
Placebo, Erythropoietin - Cerebral Malaria
Phase 2 / Phase 3UnknownClaude Bernard University1202007-10-012008-06-13
Mannitol as Adjunct Therapy for Childhood Cerebral Malaria
Mannitol - Cerebral Malaria
Phase 3UnknownMakerere University1562004-10-012005-06-24
Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria
Intrarectal quinine - Cerebral Malaria
Phase 3UnknownMakerere University1082003-09-012005-08-04

Narrower conditions

Malaria, Cerebral (5)  ·  Malaria (3)  ·  Toxoplasmosis, Congenital (2)  ·  Coma (1)  ·  Meningitis, Bacterial (1)  ·  Meningitis, Cryptococcal (1)  ·  Neglected Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurosyphilis (1)  ·  Tuberculosis, Central Nervous System (1)

Broader conditions

Central Nervous System Diseases (7)  ·  Central Nervous System Infections (7)  ·  Central Nervous System Parasitic Infections (7)  ·  Infections (7)  ·  Parasitic Diseases (7)  ·  Protozoan Infections (7)  ·  Nervous System Diseases (6)  ·  Mosquito-Borne Diseases (5)  ·  Vector Borne Diseases (5)  ·  Coccidiosis (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Infant, Newborn, Diseases (2)  ·  Malaria (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Erythropoietin (1)  ·  Mannitol (1)  ·  Pyrimethamine (1)  ·  Respiration, Artificial (1)  ·  Saline Solution, Hypertonic (1)  ·  Spiramycin (1)  ·  Sulfadiazine (1)  ·  epoetin beta (1)

Sponsors

Makerere University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire Dijon (1)  ·  Claude Bernard University (1)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Michigan State University (1)

Countries

France (2)  ·  Uganda (2)  ·  Democratic Republic of the Congo (1)  ·  Malawi (1)  ·  Mali (1)

Top investigators

Emmanuel Bottieau, MD (1)  ·  Jane Achan, MBChB (1)  ·  Laurent Mandelbrot, MD (1)  ·  Marleen Boelaert, MD, PhD (1)  ·  Terrie E Taylor, DO (1)

Results publications

PMID 17958887, PMID 19630971, PMID 19852829, PMID 34020114

NIH funding

2009 (1), U01AI126610 (1)